4/A//SEC Filing
HINSON JOHN R 4/A
Accession 0001209191-09-020430
CIK 0001323115other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 6:11 PM ET
Size
12.4 KB
Accession
0001209191-09-020430
Insider Transaction Report
Form 4/AAmended
HINSON JOHN R
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock
2008-12-19$2.85/sh+4,950$14,108→ 4,950 total - Sale
Common Stock
2008-12-19$7.66/sh−4,950$37,914→ 0 total - Exercise/Conversion
Stock Option
2008-12-19−4,950→ 170,068 totalExercise: $2.85From: 2000-08-14Exp: 2010-08-14→ Common Stock (4,950 underlying)
Footnotes (3)
- [F1]This form amends an amendment filed on 2/25/2009 to correct Table I transaction date.
- [F2]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person
- [F3]This price in Column 4 is a weighted average sales price. The prices actually paid ranged from $7.50 to $7.98. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Documents
Issuer
Cardiac Science CORP
CIK 0001323115
Entity typeother
Related Parties
1- filerCIK 0001228334
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 6:11 PM ET
- Size
- 12.4 KB